乳腺植入物相关间变性大细胞淋巴瘤:综述与多参数成像范式
乳腺植入物相关间变性大细胞淋巴瘤(BIA-ALCL)是2016年WHO淋巴肿瘤分类中的新暂定类别,随植入物置入增多其发病率上升。典型表现为植入后中位10年突发的乳房肿胀(植入物周围积液),少数为肿块型;积液型惰性可手术治愈,肿块型侵袭性需全身治疗。作者评估US、乳腺X线、MRI、CT、PET/CT的适应证与局限,提出多参数成像范式并预测未来多模态评估方向。
要点
- 植入后中位10年突发乳房肿胀伴植入物周围积液是BIA-ALCL最常见表现,肿块型较少见但更具侵袭性。
- 积液型通常惰性、可手术治愈;肿块型更具侵袭性,原文主张全身治疗。
- 现有淋巴瘤分期与疗效指南不易适用于BIA-ALCL,影像解释存在显著挑战。
核心结论
- BIA-ALCL是2016年WHO淋巴肿瘤分类的新暂定类别,随其作为乳房植入并发症被更多识别,发病率上升。
- 高临床怀疑并合理使用影像与病理方法是及时准确诊断BIA-ALCL的关键。
- 当前淋巴瘤分期与疗效指南不易适用于BIA-ALCL,其独特行为带来显著诊断与影像解释挑战。
研究设计与样本
- 综述:作者评估该领域现有证据,详述各种影像技术用于BIA-ALCL的关键适应证、优势与局限。
- 作者提出针对植入物周围积液型与肿块型或晚期病变亚型的多参数成像管理范式。
- 作者预测基于新型成像与分子技术的多模态评估未来模型,并界定关键研究方向。
关键影像表现/征象
- 典型表现为植入物置入后中位10年突发的乳房肿胀,继发于植入物周围积液;肿块形成性疾病较少见。
- 组织学为表达CD30、间变性淋巴瘤激酶(ALK)阴性的多形性细胞,与系统性和皮肤ALK阴性间变性大细胞淋巴瘤相似。
诊断标准与关键数值
- BIA-ALCL为2016年WHO淋巴肿瘤分类中的新暂定类别。
- 组织学特征:多形性细胞表达CD30且ALK受体阴性。
临床应用与阅片要点
- 对植入物置入后中位10年出现突发乳房肿胀或植入物周围积液者,应保持高临床怀疑并合理选用影像与病理方法。
- US、乳腺X线、乳腺MRI、CT和PET/CT常规用于乳腺疾病与淋巴瘤,但用于BIA-ALCL时存在显著诊断与影像解释挑战。
- 积液型通常惰性、可手术治愈;肿块型更具侵袭性,原文主张全身治疗。
局限性
- 当前淋巴瘤分期与疗效指南不易适用于BIA-ALCL。
- BIA-ALCL的独特行为带来显著诊断与影像解释挑战,许多细微影像特征相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a new provisional category in the 2016 World Health Organization (WHO) classification of lymphoid neoplasms, and its incidence is rising owing to increasing recognition of this complication of breast implant insertion. At a median of 10 years after implant insertion, the typical presenting features are sudden-onset breast swelling secondary to peri-implant effusion and less frequently mass-forming disease. Histologic features comprise pleomorphic cells expressing CD30 and negative anaplastic lymphoma kinase (ALK) receptor, similar to systemic and cutaneous ALK-negative anaplastic large cell lymphoma (ALCL). The effusion-only subtype is generally indolent and curable with surgery, unlike the more aggressive mass-forming disease, for which systemic therapy is advocated. High clinical suspicion and pertinent use of radiologic and pathology modalities are essential for timely and accurate diagnosis of BIA-ALCL. Contemporary imaging techniques including US, mammography, breast MRI, CT, and PET/CT are routinely used in breast disease and lymphomas; however, the unique behavior of BIA-ALCL presents significant diagnostic and radiologic interpretative challenges, with numerous nuanced imaging features being pertinent, and current lymphoma staging and response guidelines are not easily applicable to BIA-ALCL. The authors evaluate available evidence in this evolving field; detail key indications, strengths, and limitations of the panoply of radiologic techniques for BIA-ALCL; and propose multiparametric imaging paradigms for management of the peri-implant effusion and mass-forming or advanced disease subtypes, with the goal of accurate optimal patient care. The authors also predict a future model of multimodal assessment using novel imaging and molecular techniques and define key research directions. ©RSNA, 2020.
引用
- Sharma B, Jurgensen-Rauch A, Pace E, et al. Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms. Radiographics. 2020. PMID: 32302264. doi:10.1148/rg.2020190198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。